EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Progress and Remaining Translational Challenges for Antisense Oligonucleotides, siRNAs, miRNAs, and Aptamers as Nucleic Acid Drugs

Maryam Tabarzad

Journal of Reports in Pharmaceutical Sciences · 03.11.2026 · 14 (1)

DOI: 10.5812/jrps-175176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reports in Pharmaceutical Sciences, online erschienen am 03.11.2026. Verfasst von Maryam Tabarzad. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tabarzad, M. (2026). Progress and Remaining Translational Challenges for Antisense Oligonucleotides, siRNAs, miRNAs, and Aptamers as Nucleic Acid Drugs. Journal of Reports in Pharmaceutical Sciences, 14(1). https://doi.org/10.5812/jrps-175176

Vancouver

Tabarzad M. Progress and Remaining Translational Challenges for Antisense Oligonucleotides, siRNAs, miRNAs, and Aptamers as Nucleic Acid Drugs. Journal of Reports in Pharmaceutical Sciences. 2026;14(1). doi:10.5812/jrps-175176

BibTeX
@article{Tabarzad2026,
  author = {Tabarzad, Maryam},
  title = {Progress and Remaining Translational Challenges for Antisense Oligonucleotides, siRNAs, miRNAs, and Aptamers as Nucleic Acid Drugs},
  journal = {Journal of Reports in Pharmaceutical Sciences},
  year = {2026},
  volume = {14},
  number = {1},
  doi = {10.5812/jrps-175176}
}
Kostenlos starten →